Feedback / Questions
GB232 (adalimumab biosimilar) - Walvax, Pharma Research BIO
http://www.ncbi.nlm.nih.gov/pubmed/36082035
Sep 13, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next